ATC Group: C05BX01 Calcium dobesilate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C05BX01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C05 Vasoprotectives
3 C05B Antivaricose therapy
4 C05BX Other sclerosing agents
5 C05BX01 Calcium dobesilate

Active ingredients in C05BX01

Active Ingredient Description
Calcium dobesilate

Calcium dobesilate is a regulator of capillary functions. Calcium dobesilate acts on the capillary walls by regulating its impaired physiological functions – increased permeability and decreased resistance. It increases erythrocyte flexibility, inhibits platelet hyperaggregation and, in diabetic retinopathy, it reduces plasma and blood hyperviscosity, thus improving blood rheological properties and tissue irrigation.

Related product monographs

Title Information Source Document Type  
MEDORIL Capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

France (FR)

Hong Kong (HK)

Mexico (MX)

Romania (RO)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.